Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credits: iStock
The American Red Cross reported a severe shortage of blood that has affected Tri-City area hospitals. In the last month, there has been a 35% drop in blood supply. The 'Code Red' blood shortage in Washington created a critical situation with hospitals requesting for blood. The drop is also noted due to the winter weather that has affected donation drive.
Reports note that during the winter season, blood supply becomes challenging, though its demand may increase due to illness and severe weather conditions. However, the same factors lead to fewer donation drives that leads to critical shortage. According to Red Cross reports, more than 550 blood drives have been canceled since January 21. This has resulted in over 15,000 uncollected blood and platelet donation.
The shortage has severely impacted the availability of blood for trauma victims, cancer patients and those who require emergency surgeries. During such situation, volunteer donors play an essential role.
Diana Heilman, supervisor at the Kennewick Red Cross Fixed Site, said, "octors may face difficult decisions during a blood shortage, such as who can safely receive the products and treatments, and they will potentially have to wait because there simply isn't enough blood available."
Type O is a universal donor, while Type O positive is the most commonly transfused blood type. A negative blood type is found in only 6% of the population, and B negative is less than 2%.
Red Cross also announced a $20 e-gift card for those who donate between January 26 to February 28, as incentive.
Read: Japan Races To Develop World’s First Artificial Blood, Trials To Begin
Must be in good general health, weigh at least 110 pounds, and be 17 years old (or 16 with parental consent where permitted)
Read: Thinking of Donating Blood? A Doctor Answers All Your Doubts
This is one of the most common concerns, especially among first-time female donors. According to Dr. Sangeeta Pathak, Director and Head of Transfusion Medicine at Max Super Speciality Hospital, Saket, who spoke to Health and Me, as per the Drugs and Cosmetics Act, women are advised not to donate during their menstruation, particularly during the 4-5 days of active bleeding. However, they are completely eligible to donate at any other time of the month if they are in good health.
Health is key when it comes to blood donation. “A person should be completely healthy and free from fever or illness at the time of donation,” says Dr. Pathak. Moreover, certain medications can lead to deferral, and there is a comprehensive list maintained under the Drugs and Cosmetics Act. So if you’re on a prescribed course, it’s best to consult a doctor or the blood bank before donating.
Yes. If you’ve recently had a tattoo or body piercing, you’ll need to wait 12 months before you can donate blood. This is a precautionary step to ensure there’s no risk of transmitting infections.
Credits: iStock
Statin pain and what is it, scientists finally explain. A study by University of British Columbia finally explained what statin muscle pain is and what triggers it. Statins have long been a cornerstone of cardiovascular care. By lowering “bad” LDL cholesterol, these drugs have significantly reduced the risk of heart attacks and strokes for millions worldwide. Yet, for a notable number of users, statins come with an uncomfortable trade-off: muscle pain, weakness, and, in rare cases, severe muscle breakdown that can even lead to kidney failure.
For years, doctors have known that these side effects occur, but not why. Now, a new study offers a detailed answer.
Researchers from the University of British Columbia (UBC), in collaboration with the University of Wisconsin–Madison, have identified the molecular trigger behind statin-related muscle problems. Their findings, published in Nature Communications, could pave the way for safer cholesterol-lowering drugs in the future.
Muscle-related side effects are among the most common reasons people stop taking statins. Symptoms range from mild soreness and fatigue to rhabdomyolysis, a rare but dangerous condition where muscle tissue breaks down and releases proteins that can damage the kidneys.
Until now, the biological mechanism behind this damage remained unclear. The new research zooms in on what happens inside muscle cells when statins are present.
To understand the problem, researchers focused on a protein called the ryanodine receptor (RyR1), which plays a critical role in muscle contraction. RyR1 acts as a gatekeeper, controlling the release of calcium inside muscle cells. Calcium is essential for muscle movement, but only in carefully regulated amounts.
Using cryo-electron microscopy, an advanced imaging technique that allows scientists to view proteins in near-atomic detail—the team observed how statins interact with this receptor.
What they found was striking: when statins bind to RyR1, they force the channel to remain open. This leads to a constant leak of calcium into the muscle cell. Over time, this calcium overload becomes toxic, damaging muscle tissue and explaining the pain, weakness, and, in severe cases, muscle breakdown seen in some patients.
The study examined atorvastatin, one of the most widely prescribed statins globally. However, researchers suggest the same mechanism may apply across the statin class.
They discovered that statins bind to RyR1 in an unusual three-part formation. One statin molecule attaches while the channel is closed, priming it to open. Two additional molecules then bind, forcing the channel fully open and keeping it that way. This sustained opening is what causes the harmful calcium leak.
This detailed binding pattern offers the clearest explanation yet for statin-induced muscle side effects.
While severe muscle injury affects only a small fraction of the more than 200 million statin users worldwide, milder symptoms are far more common and often lead patients to discontinue treatment. This is a serious concern, as stopping statins increases cardiovascular risk.
The new findings provide a potential solution. By modifying the parts of statin molecules that interact with RyR1—while preserving their cholesterol-lowering effects—scientists may be able to develop safer statins with fewer muscle-related side effects.
Beyond statins, the research highlights how advanced imaging technologies are transforming medicine. By visualizing drug–protein interactions at near-atomic resolution, scientists can move from observing side effects to understanding their exact cause.
For patients, this could mean a future where statins remain just as effective—but far easier on the muscles, improving long-term adherence and overall quality of life.
Credits: PR Thai Government (X)
Nipah virus outbreak in India triggered airport screenings of travelers. Many reports claim that passengers are being checked in similar ways as they were during the COVID-19 virus spread.
In Thailand, health officials have announced: "passenger screening points for arrival from affected areas" on its official X account, along with the information on airports to start "enhanced cleaning of shared areas to ensure the safety of both passengers and staff".
On January 27, Thailand's Tourism Ministry announced that they had "not detected any cases of Nipah virus, affirming that strict screening and preventive measures are in place at all international airports to safeguard public health and reassure tourists."
The screening includes:
Anyone suspected of having Nipah will be immediately isolated and referred to public health system "in accordance with International Health Regulations".
Read: Australia Is Monitoring Nipah Virus Outbreak In India
In Thailand, the screenings are happening in these following airports:

Two cases of Nipah virus were detected in India's eastern state of West Bengal, in Kolkata. While other airports have also geared up for travel checks, Thailand is taking it to a next level with COVID-19 like checks. The reason is due to a huge number of international travel form Kolkata to Bangkok and Phuket. Many reports claim that Thailand is a premier international destination for travelers from Kolkata, due to its proximity, affordability, and being a visa-free detination. There are roughly 55 weekly direct flights from Netaji Subhash Chandra Bose International Airport to Bangkok and Phuket.
As per the World Health Organization (WHO), Nipah virus infection is a zoonotic illness that is transmitted to people from animals, and can also be transmitted through contaminated food or directly from person to person.
In infected people, it causes a range of illnesses from asymptomatic (subclinical) infection to acute respiratory illness and fatal encephalitis. The virus can also cause severe disease in animals such as pigs, resulting in significant economic losses for farmers.
Read: Nipah Virus Outbreak In India: How Did It All Begin?
Although Nipah virus has caused only a few known outbreaks in Asia, it infects a wide range of animals and causes severe disease and death in people.
Nipah virus is infectious and can spread from animals like bats and pigs to humans through bodily fluids or contaminated food. It can also pass between people through close contact, especially in caregiving settings. While it can spread via respiratory droplets in enclosed spaces, it is not considered highly airborne and usually requires close, prolonged contact for transmission. Common routes include direct exposure to infected animals or their fluids, consuming contaminated fruits or date palm sap, and contact with bodily fluids such as saliva, urine, or blood from an infected person.
© 2024 Bennett, Coleman & Company Limited